Peginterferon α-2a (40 kda) plus ribavirin in chronic hepatitis C patients who failed previous interferon-based therapy:: Results of a multicentre open-label expanded access program in Canada

被引：0
|
作者：
Sherman, M
Yoshida, E
Deschenes, M
Krajden, M
Bain, V
Peltekian, K
Anderson, E
Kaita, K
Simonyi, S
Lee, S
机构：
[1] Toronto Gen Hosp, Univ Hlth Network, Dept Med, Toronto, ON, Canada
[2] Vancouver Gen Hosp, Hlth Sci Ctr, Dept Med, Vancouver, BC, Canada
[3] Royal Victoria Hosp, Montreal, PQ H3A 1A1, Canada
[4] British Columbia Ctr Dis Control, Vancouver, BC, Canada
[5] Univ Alberta, Dept Med, Edmonton, AB, Canada
[6] QEII, Hlth Sci Ctr, Serv Hepatol, Halifax, NS, Canada
[7] Liver & Intestinal Res Ctr, Vancouver, BC, Canada
[8] John Buhler Res Ctr, Winnipeg, MB, Canada
[9] Roche, Mississauga, ON, Canada
[10] Univ Calgary, Calgary, AB, Canada
来源：
JOURNAL OF HEPATOLOGY | 2005年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
603
引用
下载
收藏
页码：220 / 220
页数：1
相关论文
共 50 条
  • [1] Peginterferon α-2a (40kDa) plus ribavirin in cirrhotic patients with chronic hepatitis C:: Results of a Canadian multicenter open-label expanded access program
    Lee, SS
    Bain, V
    Peltekian, K
    Krajden, M
    Yoshida, E
    Deschenes, M
    Heathcote, EJ
    Bailey, R
    Simonyi, S
    Sherman, M
    JOURNAL OF HEPATOLOGY, 2005, 42 : 210 - 210
  • [2] Predictability of an early virological response with peginterferon alfa-2a (40KD) plus ribavirin in the 'real world' :: Results of a multicentre open-label expanded access program for patients with chronic hepatitis C in Canada
    Peltekian, K
    Krajden, M
    Deschênes, M
    Bain, V
    Anderson, F
    Kaita, K
    Heathcote, J
    Bailey, R
    Sherman, M
    Lee, S
    Yoshida, E
    Simonyi, S
    GASTROENTEROLOGY, 2005, 128 (04) : A721 - A721
  • [3] Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapy
    Sherman, M.
    Yoshida, E. M.
    Deschenes, M.
    Krajden, M.
    Bain, V. G.
    Peltekian, K.
    Anderson, F.
    Kaita, K.
    Simonyi, S.
    Balshaw, R.
    Lee, S. S.
    GUT, 2006, 55 (11) : 1631 - 1638
  • [4] 'real' world experience with peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C:: Results of a multicenter open-label expanded access program in Canada
    Yoshida, E
    Heatheote, J
    Bailey, R
    Anderson, F
    Kaita, K
    Krajden, M
    Deschênes, M
    Bain, V
    Lee, S
    Sherman, M
    Peltekian, K
    Simonyi, S
    GASTROENTEROLOGY, 2005, 128 (04) : A723 - A723
  • [5] Open-label study of faldaprevir plus peginterferon and ribavirin in hepatitis C virus genotype 1-infected patients who failed placebo plus peginterferon and ribavirin
    Foster, G. R.
    Ferenci, P.
    Asselah, T.
    Mantry, P.
    Dufour, J. -F.
    Bourliere, M.
    Forton, D.
    Maevskaya, M.
    Wright, D.
    Yoshida, E. M.
    Garcia-Samaniego, J.
    Oliveira, C.
    Wright, M.
    Warner, N.
    Sha, N.
    Quinson, A. -M.
    Stern, J. O.
    JOURNAL OF VIRAL HEPATITIS, 2016, 23 (03) : 227 - 231
  • [6] PREDICTORS OF PREMATURE WITHDRAWAL AND DOSE REDUCTIONS IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGINTERFERON ALFA-2A (40KD) (PEGIFNα2A) PLUS RIBAVIRIN IN A LARGE, MULTINATIONAL, OPEN-LABEL EXPANDED ACCESS PROGRAM
    Lee, Samuel S.
    Roberts, Stuart K.
    Berak, Hanna
    Dusheiko, Geoffrey M.
    Harley, Hugh
    Gane, Edward J.
    Husa, Petr
    Horsmans, Yves J.
    Han, Kwang-Hyub
    Hadziyannis, Stephanos J.
    Heathcote, E. Jenny
    Messinger, Diethelm
    Tietz, Andreas
    Ferenci, Peter
    HEPATOLOGY, 2009, 50 (04) : 717A - 717A
  • [7] Peginterferon-α-2a (40kD) and ribavirin in patients with chronic hepatitis C -: A phase II open-label study
    Sulkowski, M
    Reindollar, R
    Thomas, DL
    Brinkley-Laughton, S
    Hudson, M
    Yu, F
    BIODRUGS, 2002, 16 (02) : 105 - 109
  • [8] Efficacy and safety of peginterferon α-2a (40 kD) plus ribavirin among patients with chronic hepatitis C and earlier treatment failure to interferon and ribavirin: an open-label study in central and Eastern Europe
    Husa, Petr
    Oltman, Marian
    Ivanovski, Ljubomir
    Rehak, Vratislav
    Messinger, Diethelm
    Tietz, Andreas
    Urbanek, Petr
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2011, 23 (05) : 375 - 381
  • [9] Peginterferon Alfa-2a plus Ribavirin in Japanese Patients Infected with Hepatitis C Virus Genotype 2 Who Failed Previous Interferon Therapy
    Kanda, Tatsuo
    Nakamoto, Shingo
    Nishino, Takayoshi
    Takada, Nobuo
    Tsubota, Akihito
    Kato, Keizo
    Miyamura, Tatsuo
    Maruoka, Daisuke
    Wu, Shuang
    Tanaka, Takeshi
    Arai, Makoto
    Mikami, Shigeru
    Fujiwara, Keiichi
    Imazeki, Fumio
    Yokosuka, Osamu
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2013, 10 (01): : 43 - 49
  • [10] Peginterferon α-2a (40 KD) plus ribavirin for the treatment of chronic hepatitis C in Japanese patients
    Kuboki, Makoto
    Iino, Shiro
    Okuno, Tadao
    Omata, Masao
    Kiyosawa, Kendo
    Kumada, Hiromitsu
    Hayashi, Norio
    Sakai, Takahiro
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (05) : 645 - 652
12345